PLoS ONE (Jan 2018)

Red cell distribution width and renal outcome in patients with non-dialysis-dependent chronic kidney disease.

  • Sayoko Yonemoto,
  • Takayuki Hamano,
  • Naohiko Fujii,
  • Karin Shimada,
  • Satoshi Yamaguchi,
  • Ayumi Matsumoto,
  • Keiichi Kubota,
  • Nobuhiro Hashimoto,
  • Tatsufumi Oka,
  • Masamitsu Senda,
  • Yusuke Sakaguchi,
  • Isao Matsui,
  • Yoshitaka Isaka

DOI
https://doi.org/10.1371/journal.pone.0198825
Journal volume & issue
Vol. 13, no. 6
p. e0198825

Abstract

Read online

Higher red cell distribution width (RDW) has been reported to predict mortality among patients with various diseases, including chronic kidney disease (CKD). However, whether RDW is associated with renal outcome remains unclear. We investigated the relationship between RDW and renal outcome in patients with non-dialysis-dependent CKD (NDD-CKD). This prospective, observational study of patients with CKD was conducted at a single nephrology department. First, we performed regression analyses for the decline in estimated glomerular filtration rate (eGFR) during the first 3 months of observation to determine its short-term association with RDW. Next, we categorized baseline RDW into two groups by its median (13.5%) and performed Cox regression analyses to investigate whether higher RDW was an independent predictor of renal outcomes defined as a composite of the initiation of dialysis and doubling of the serum creatinine concentration. Furthermore, we repeated the analyses to confirm whether the transition of the RDW category during the first 3 months would also predict renal outcomes. We enrolled 703 patients. Baseline RDW showed a non-linear association with the eGFR decline during the first 3 months, with a greater negative correlation at the lower end of the RDW distribution. Over a median follow-up of 1.8 years, 178 patients (25.3%) reached the renal endpoint. Multivariable Cox regression analyses showed that patients with higher RDW had a higher risk of developing renal outcomes (adjusted hazard ratio [HR]: 1.47, 95% confidence interval [CI]: 1.05-2.07) than did those with lower RDW. Furthermore, patients with sustained, higher RDW demonstrated a significantly higher risk than did those with consistently lower RDW (adjusted HR: 1.65, 95% CI: 1.02-2.67). In conclusion, higher RDW was independently associated with worse renal outcome in patients with NDD-CKD. RDW could be an additional prognostic marker of the progression of CKD.